Form 8-K
SEC Filings
Form 8-K is the “current report” companies file to disclose material events between periodic reports — such as trial results, FDA decisions, executive changes, or financings. Many biotech catalysts are first disclosed in an 8-K.
Related terms
Track Form 8-K across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free